CARDAMYST Trademark

Trademark Overview


On Wednesday, July 12, 2023, a trademark application was filed for CARDAMYST with the United States Patent and Trademark Office. The USPTO has given the CARDAMYST trademark a serial number of 98080988. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, September 26, 2024. This trademark is owned by Milestone Pharmaceuticals USA, Inc.. The CARDAMYST trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations; medicated nasal spray preparations; nasal sprays for medical purposes; medicated nasal sprays containing L-type calcium channel blockers; pharmaceutical preparations, namely, intranasal spray for acute treatment and relief of cardiovascular and non-cardiovascular disorders

Medical devices and instruments in the nature of nasal spray delivery devices; medical devices for administering medicines in the nature of nasal spray delivery devices; medical devices for facilitating the intranasal application of pharmaceutical preparations for acute treatment and relief of cardiovascular and non-cardiovascular disorders
cardamyst

General Information


Serial Number98080988
Word MarkCARDAMYST
Filing DateWednesday, July 12, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations; medicated nasal spray preparations; nasal sprays for medical purposes; medicated nasal sprays containing L-type calcium channel blockers; pharmaceutical preparations, namely, intranasal spray for acute treatment and relief of cardiovascular and non-cardiovascular disorders
Goods and ServicesMedical devices and instruments in the nature of nasal spray delivery devices; medical devices for administering medicines in the nature of nasal spray delivery devices; medical devices for facilitating the intranasal application of pharmaceutical preparations for acute treatment and relief of cardiovascular and non-cardiovascular disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 10, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMilestone Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCharlotte, NC 28277

Party NameMilestone Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharlotte, NC 28277

Trademark Events


Event DateEvent Description
Saturday, July 15, 2023NEW APPLICATION ENTERED
Thursday, August 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 20, 2024ASSIGNED TO EXAMINER
Monday, March 25, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, March 25, 2024EXAMINERS AMENDMENT E-MAILED
Monday, March 25, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 26, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU EXTENSION 1 GRANTED
Thursday, September 26, 2024SOU EXTENSION 1 FILED
Tuesday, June 25, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT